scispace - formally typeset
Journal ArticleDOI

Outpatient versus inpatient treatment for patients with acute pulmonary embolism : an international, open-label, randomised, non-inferiority trial.

TLDR
In selected low-risk patients with pulmonary embolism, outpatient care can safely and effectively be used in place of inpatient care.
About
This article is published in The Lancet.The article was published on 2011-07-02. It has received 507 citations till now. The article focuses on the topics: Ambulatory care & Inpatient care.

read more

Citations
More filters
Journal ArticleDOI

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

Behnood Bikdeli, +50 more
TL;DR: The current understanding of the pathogenesis, epidemiology, management and outcomes of patients with COVID-19 who develop venous or arterial thrombosis, and of those with preexistingThrombotic disease who develop CO VID-19 are reviewed.
Journal ArticleDOI

2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

TL;DR: Guidelines summarize and evaluate all available evidence at the time of the writing process, on a particular issue with the aim of assisting health professionals in selecting the best management strategies for an individual patient, with a given condition, taking into account the impact on outcome.
References
More filters
Journal ArticleDOI

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients: Definitions of major bleeding in clinical studies

TL;DR: A definition of major bleeding in non‐surgical patients was developed that should be applicable to studies with all agents that interfere with hemostasis, including anticoagulants, platelet function inhibitors and fibrinolytic drugs.
Journal ArticleDOI

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.

TL;DR: A definition of major bleeding that should be applicable to all agents that interfere with hemostasis is developed and is to seek approval from the regulatory authorities to enhance its incorporation into future clinical trial protocols.
Journal ArticleDOI

Dabigatran versus warfarin in the treatment of acute venous thromboembolism

TL;DR: For the treatment of acute venous thromboembolism, a fixed dose of dabigatran is as effective as warfarin, has a safety profile that is similar to that of warfar in, and does not require laboratory monitoring.
Related Papers (5)